Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 22;39(17):2325-2327.
doi: 10.1016/j.vaccine.2021.03.066. Epub 2021 Mar 22.

Are vaccines against COVID-19 tailored to the most vulnerable people?

Raffaele Antonelli Incalzi  1 , Caterina Trevisan  2 , Susanna Del Signore  3 , Stefano Volpato  4 , Stefano Fumagalli  5 , Fabio Monzani  6 , Giuseppe Bellelli  7 , Pietro Gareri  8 , Enrico Mossello  5 , Alba Malara  9 , Alessandra Coin  10 , Gianluca Zia  3 , Anette Hylen Ranhoff  11
Affiliations

Are vaccines against COVID-19 tailored to the most vulnerable people?

Raffaele Antonelli Incalzi et al. Vaccine. .
No abstract available

Keywords: COVID-19; Frailty; Older people; Vaccines.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Crooke S.N., Ovsyannikova I.G., Poland G.A., Kennedy R.B. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16:1–16. doi: 10.1186/s12979-019-0164-9. - DOI - PMC - PubMed
    1. ICH topic E7 Studies in Support of Special Populations: Geriatrics Questions and Answers Step 5 European medicines Agency July 2010 EMA/CHMP/ICH/604661/2009 Committee for medicinal products for human use (CHMP) n.d. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e-7-stud... [accessed November 18, 2020].
    1. Robertson C.A., DiazGranados C.A., Decker M.D., Chit A., Mercer M., Greenberg D.P. Fluzone® High-Dose Influenza Vaccine. Expert Rev Vaccines. 2016;15:1495–1505. doi: 10.1080/14760584.2016.1254044. - DOI - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 doi: 10.1056/NEJMoa2034577. NEJMoa2034577. - DOI - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed

Substances